Problems of diagnosis of acute coronary syndrome and markers of unfavorable prognosis in patients with diabetes mellitus
Abstract
Diabetes is a common comorbidity in patients hospitalized for acute coronary syndrome, and its prevalence is increasing. Among patients hospitalized with acute myocardial infarction, diabetes may be an independent predictor of mortality and new cardiovascular events; Both short- and long-term outcomes are worse for patients with diabetes compared to those without, and undiagnosed diabetes is associated with greater mortality. Cardiovascular disease and insulin resistance are closely related. Triglyceride-glucose index and glychemoglobin are often used as indicators of insulin resistance. However, there is scant information on the triglyceride-glucose index in the prediabetic population, and the prognostic value of the index in patients with diabetes and acute coronary syndrome is unknown.
About the Authors
S. U. Asadov
State Institution “Tajik Research Institute of Preventive Medicine”
Tajikistan
Tajikistan
Asadov Safarali Umaralievich – applicant
Tel: +992988576666
I. B. Gairatova
State Institution “Tajik Research Institute of Preventive Medicine”
Tajikistan
Tajikistan
F. P. Nosirova
SEI “Institute of Postgraduate Education in the Field of Health of the Republic of Tajikistan”
Tajikistan
Tajikistan
References
1. Alekseeva M.A. Ostriy koronarniy sindrom pri sakharnom diabete [Acute Coronary Syndrome in Diabetes Mellitus]. Klinicheskaya phiziologiya krovoobrasheniya - Clinical Physiology of Blood Circulation, 2018, Vol. 15, No. 3. P.162-168.
2. Barbarash O.L. Ostryy koronarnyy sindrom bez pod”yema segmenta ST elektrokardiogrammy. Klinicheskiye rekomendatsii 2020 [Acute coronary syndrome without ST segment elevation of the electrocardiogram. Clinical recommendations 2020]. Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology. 2021; V. 26, No. 4; P.4449.
3. Belyaeva N.G. Sakharniy diabet 2 tipa, kak faktor riska serdechno-sosudistikh zabolevaniy [Diabetes mellitus of the 2nd type, as a risk factor of cardiovascular diseases]. Uralskiy medisinskiy jurnal - Ural Medical Journal, 2019, №1(169). P. 56-61.
4. Garganeeva A.A. Sakharnyy diabet 2 tipa i ostryy infarkt miokarda: prognosticheskiye varianty vzaimodeystviya u patsiyentov raznykh vozrastnykh grupp. [Type 2 diabetes mellitus and acute myocardial infarction: prognostic options for interaction in patients of different age groups] Sakharnyy diabet – Diabetes mellitus. 2018; V.21, No. 2; P. 105-12.
5. Golikov A.P. Faktory prognoza u patsiyentov s ostrym koronarnym sindromom bez pod”yema segmenta ST v sochetanii s sakharnym diabetom 2 tipa (po rezul’tatam registra) [Prognosis factors in patients with acute coronary syndrome without ST segment elevation in combination with type 2 diabetes mellitus (according to the results of the register)]. Terapevticheskiy arkhiv – Therapeutic archive. 2017; No. 3; pp. 65-71.
6. Zykov M.V. Vozmozhnosti sovmestnogo ispol’zovaniya shkaly GRACE i razlichnykh indeksov komorbidnosti dlya povysheniya effektivnosti otsenki riska gospital’noy letal’nosti u bol’nykh s ostrym koronarnym sindromom [Possibilities of joint use of the GRACE scale and various comorbidity indices to improve the efficiency of assessing the risk of hospital mortality in patients with acute coronary syndrome]. Terapevticheskiy arkhiv – Therapeutic archive. 2022; V. 94, No. 7; P. 816-821.
7. Korotina M. A. Glikemiya u bol’nykh sakharnym diabetom 2 tipa vo vremya statsionarnogo lecheniya po povodu ostrogo infarkta miokarda: vliyaniye na prognoz [Glycemia in patients with type 2 diabetes mellitus during hospital treatment for acute myocardial infarction: impact on forecast]. Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology. 2021; V.26, No. 3; P. 15-21.
8. Nikitina Ye.A. Prognozirovaniye riska neblagopriyatnykh serdechno-sosudistykh sobytiy v otdalennom periode posle epizoda ostrogo koronarnogo sindroma na fone sakharnogo diabeta 2 tipa [Prediction of the risk of adverse cardiovascular events in the long-term period after an episode of acute coronary syndrome due to type 2 diabetes mellitus]. Kardiovaskulyarnaya terapiya i profilaktika - Cardiovascular therapy and prevention, 2020, Vol.19(3), P. e2357.
9. Rossiyskoye kardiologicheskoye obshchestvo. Ostryy infarkt miokarda s pod”yemom segmenta ST elektrokardiogrammy. Klinicheskiye rekomendatsii 2020 [Russian Cardiological Society. Acute myocardial infarction with ST segment elevation of the electrocardiogram. Clinical recommendations 2020]. Rossiyskiy kardiologicheskiy zhurnal - Russian Journal of Cardiology, 2020, Vol. 25(11), P. 251-310.
10. Svarovskaya A.V. Prediktory razvitiya neblagopriyatnykh serdechno-sosudistykh sobytiy u patsiyentov s ishemicheskoy bolezn’yu serdtsa, perenesshikh chreskozhnoye koronarnoye vmeshatel’stvo [Predictors of the development of adverse cardiovascular events in patients with coronary heart disease who underwent percutaneous coronary intervention]. Rossiyskiy kardiologicheskiy zhurnal - Russian Journal of Cardiology, 2020, Vol. 25(6), P. 3938.
11. Tabarov A.I. Prediktory riska vozniknoveniya ishemicheskoy bolezni serdtsa i infarkta miokarda [Predictors of the risk of coronary heart disease and myocardial infarction]. Yevraziyskiy nauchno-meditsinskiy zhurnal «Sino»-Eurasian scientific and medical journal “Sino”, 2023, Vol. 4, No. 1, P. 12-18.
12. Shukurova S.M. Vybor sovremennoy strategii lecheniya ostrogo koronarnogo sindroma s pod”yemom segmenta ST [Selection of a modern strategy for the treatment of acute coronary syndrome with ST segment elevation]. J. Zdravookhraneniya Tadzhikistana - Journal of Healthcare of Tajikistan, 2022, No.3, P. 119-127.
13. Shukurova S.M. Nekotoryye aspekty komorbidnosti pri infarkte miokarda [Some aspects of comorbidity in myocardial infarction] // Ж ZH. Vestnik poslediplomnogo obrazovaniya v sfere zdravookhraneniya - J. Bulletin of postgraduate education in the field of health care. 2020; No 4, P. 99-106.
14. 2019 Rekomendatsii YeSC/EASD po sakharnomu diabetu, prediabetu i serdechno-sosudistym zabolevaniyam [2019 ESC/EASD recommendations on diabetes mellitus, prediabetes and cardiovascular diseases] Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology. 2020; T.25, No. 4; P.3839.
15. Babes E.E., Bustea C., Behl T., et al. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy // Biomedicine & Pharmacotherapy. 2022, Vol. 148, P. e112772.
16. Behl T., Bungau S., Kumar K., Zengin G. et al. Pleotropic effects of polyphenols in cardiovascular system / /Biomed. Pharmacother. 2020; vol. 130: P. e110714.
17. Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 //Cardiovasc Diabetol. 2018; vol.17, no 1: P.e83.
18. Guo Q., Feng X., Zhang B, et al. Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients with Acute Coronary Syndrome // Front Endocrinol (Lausanne). 2022; Vol.13: P.e843072.
19. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction // N Engl J Med. 1998 Jul 23; Vol. 339, No. 4: P. 229-234.
20. Hendricks S., Dykun I., Balcer B., Totzeck M., Rassaf T., Mahabadi A.A. Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction - a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study // Medicine (Baltimore). 2021; Vol.100(52): P. e28060.
21. Khan F.R., Ali J., Ullah R., Hassan Z., et al. Relationship Between High Glycated Hemoglobin and Severity of Coronary Artery Disease in Type II Diabetic Patients Hospitalized with Acute Coronary Syndrome // Cureus. 2021; Vol.13, No 3: P. e13734.
22. Luo E., Wang D., Yan G., et al. High triglycerideglucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention // Cardiovasc Diabetol. 2019; Vol. 18, P. e150.
23. Marx N., Federici M., Schutt K., Muller-Wieland D. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes // Eur. Heart J. 2023; Vol.44: P. 4043-4140.
24. Mazidi M., Kengne A.P., Katsiki N., Mikhailidis D.P., Banach M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance // J Diabetes Complications, 2018; Vol.32: P. 266-270.
25. Oktay A.A., Akturk H.K., Esenboga K., Javed F. et al. Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus //Curr. Probl. Cardiol. 2018; Vol. 43: P. 68-110. doi: 10.1016/j.cpcardiol.2017.05.001
26. Ormazabal V., Nair S., Elfeky O., Aguayo C., Salomon C., Zuñiga F.A. Association between insulin resistance and the development of cardiovascular disease // Cardiovasc Diabetol, 2018; Vol.17, P. 122.
27. Patti G., I. Cavallari, F. Andreotti, P. Calabrò, P. Cirillo, G. Denas, M. Galli, E. Golia, E. Maddaloni, R. Marcucci, et al. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs //Nat. Rev. Cardiol. 2019; Vol. 16: pp. 113-130.
28. Poznyak A., Grechko A.V., Poggio P., et al. The Diabetes Mellitus-Atherosclerosis Connection: the Role of Lipid and Glucose Metabolism and Chronic Inflammation // Int J Mol Sci. 2020; Vol. 21, P. 5.
29. Qin Z., Xu S., Yuan R., Wang Z., et al. Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI. //Diabetes Metab Syndr Obes. 2022; Vol.15: pp. 3015-3025.
30. Saeedi P., Petersohn I., Salpea P., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas // Diabetes Research and Clinical Practice. 2019; Vol.157, P.e107843
31. Tang L., Li K., Wu C.J. Thirty-day readmission, length of stay and self-management behaviour among patients with acute coronary syndrome and type 2 diabetes mellitus: A scoping review // J. Clin. Nurs. 2020; vol. 29: P. 320-329.
32. Wang L., Cong H.L., Zhang J.X., et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome // Cardiovasc Diabetol. 2020; Vol.19, No 1: P.e80.
33. Yaribeygi H., Farrokhi F.R., Butler A.E., Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–8161. doi: 10.1002/jcp.27603
34. Zhang Y., Ding X., Hua B., et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction // Nutr Metab Cardiovasc Dis. 2020; Vol.30, No. 12, P. 2351-2362.
35. Zhao Q., Zhang T.Y., Cheng Y.J., et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention //J Atheroscler Thromb. 2021; Vol. 28(11), P. 1175-1194.
Review
For citations:
Asadov S.U., Gairatova I.B., Nosirova F.P. Problems of diagnosis of acute coronary syndrome and markers of unfavorable prognosis in patients with diabetes mellitus. Herald of the medical and social institute of Tajikistan. 2024;(2):74-84. (In Russ.)
Views:
64
Email this article 